We are now enrolling for a clinical trial evaluating the effectiveness of an oral treatment on individuals with rebound COVID-19.
A small number of people who have COVID-19 experience a return of signs/symptoms after initially feeling better, including those that have received treatment.
We have partnered with a sponsor to evaluate the effectiveness of an oral treatment on high-risk individuals who are experiencing rebound COVID-19 symptoms after initial treatment.
If you are interested in participating in this study or have questions about your eligibility, perform a self-check below and request a phone screen.
Download Study Flyer
Participant Enrollment Criteria
12 years of age or older
Previous infection of COVID-19 with symptom alleviation followed by a worsening of signs/symptoms after completing a COVID-19 treatment.
One or more underlying medical condition associated with an increased risk of developing severe illness from COVID-19.
Additional criteria may apply
Participants Will Receive
Receive access to study related medical equipment and care
Receive compensation up to $1100
Location and Time
All appointments are located at Eastside Research Associates in Redmond, WA
8 in-clinic visits over the course of 24 weeks.